Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.2%

1 terminated out of 24 trials

Success Rate

92.3%

+5.8% vs benchmark

Late-Stage Pipeline

25%

6 trials in Phase 3/4

Results Transparency

8%

1 of 12 completed with results

Key Signals

1 with results92% success

Data Visualizations

Phase Distribution

23Total
Not Applicable (12)
Early P 1 (1)
P 1 (1)
P 2 (3)
P 3 (6)

Trial Status

Completed12
Unknown4
Recruiting3
Not Yet Recruiting2
Terminated1
Active Not Recruiting1

Trial Success Rate

92.3%

Benchmark: 86.5%

Based on 12 completed trials

Clinical Trials (24)

Showing 20 of 20 trials
NCT05308732Phase 1Active Not Recruiting

Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to Radiotherapy

NCT07183267Not ApplicableNot Yet Recruiting

Using Red Light Therapy to Ease Skin Side Effects and Mouth Side Effects, in Children and Young People Aged 0 to 16 Years Old, Receiving Radiotherapy

NCT06031012Phase 3CompletedPrimary

Glutamine Combined With Thalidomide in Preventing Radiation-induced Oral Mucositis

NCT03983369Phase 3RecruitingPrimary

Low-level Laser Therapy in the Prevention of Chemotherapy-induced Mucositis in Children and Young Adults

NCT05926297Not ApplicableCompleted

Treatment of Peri-implant Mucositis by Sodium Hypochlorite Gel and Cross-linked Hyaluronic Acid Gel

NCT06623305Not ApplicableNot Yet RecruitingPrimary

A Clinical Trial of the Administration of Light Therapy to Prevent and Treat Mouth Sores in Children With Cancer

NCT05278260Early Phase 1CompletedPrimary

Hydrogen-rich Water and Treatment of Mucositis Caused by Radiation Therapy in Head and Neck Cancer Patients

NCT03461354Not ApplicableTerminatedPrimary

MucoLox Formulation to Mitigate Mucositis Symptoms in Head/Neck Cancer

NCT04080622Phase 3CompletedPrimary

Evaluate the Efficacy of Selenium for the Prevention of Chemotherapy-induced Mucositis During Autologous Stem Cell Transplantation.

NCT06711315Not ApplicableCompleted

Oral Mucositis Management in Pediatric Oncology Patients

NCT05926557Not ApplicableRecruiting

Treatment of Peri-implant Mucositis by Application of a Spermidine-based Gel

NCT04671862Not ApplicableRecruitingPrimary

Photobiomodulation for the Prevention of Radiation Induced Oral Mucositis

NCT05331131Phase 2Withdrawn

Efficacy of Ketamine Mouthwash in the Management of Oral and Pharyngeal Toxicity Associated With Head and Neck Chemoradiotherapy: A Phase 2, Simon 2-stage Trial

NCT06217224Not ApplicableUnknownPrimary

Evaluation of Prophylactic Photobiomodulation Therapy in Patients With Osteosarcoma

NCT06049511Not ApplicableCompletedPrimary

Oral Self Care Protocol and Oral Mucositis

NCT04596410Not ApplicableUnknownPrimary

Photobiomodulation Protocols in the Analgesia of Chemotherapy-induced Oral Mucositis in Children

NCT05214495Phase 2CompletedPrimary

Omega-3 Hydrogel and Prevention of Oral Mucositis

NCT05224882UnknownPrimary

Chemotherapy Oral Manifestations and Dental Awareness Among Parents

NCT05307445Not ApplicableCompletedPrimary

Treatment of Peri-Implant Mucositis With Standard of Care and Bioptron Hyperlight Therapy

NCT04303312Phase 3UnknownPrimary

Treatment of Chemotherapy and Radiotherapy Induced Oral Mucositis

Scroll to load more

Research Network

Activity Timeline